Adam Moss, MD
Ophthalmology · Edina, MNNPI 1093032435
Payments from drug & device makers
What this record shows
This record is dominated by other: $7,475 of the $8,610 with a category attached, or 86.8%. Glaukos Corporation accounts for 91.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $7,689 and has fallen 97.2% since, to $214 in 2025. Among ophthalmology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $226.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$8K
- Alcon$246
- Johnson & Johnson Surgical Vision, Inc.$151
- Novartis$68
- The Cameron-ehlen Group, Inc.$41
- Beaver-visitec International, Inc.$32
- plus $162 from 10 others
Across 14 payments — averaging $4025.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$56K
What the payments were for
- Food & beverage$1,11613%
- Gifts$190%
- Other$7,47587%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 10 | $7,909 |
| Alcon | 7 | $246 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $151 |
| Novartis | 4 | $68 |
| The Cameron-ehlen Group, Inc. | 2 | $41 |
| Beaver-visitec International, Inc. | 1 | $32 |
| Harrow Eye, LLC | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Oyster Point Pharma, Inc. | 1 | $18 |
| Dompe US, Inc. | 1 | $16 |
| Ocular Therapeutix, Inc. | 1 | $15 |
| Coopervision Inc. | 1 | $15 |
| Tarsus Pharmaceuticals, Inc. | 1 | $14 |
| Rxsight Inc | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LenSx$137
How this compares
$8,610 in reported general payments places this provider in the 90th percentile of 330 ophthalmology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 45 | $59,243 |
| XiidraLifitegrast | 28 | $34,143 |
| Fluorometholone | 240 | $19,509 |
| Cyclosporine | 12 | $11,544 |
| Prednisolone Acetate | 197 | $7,068 |
| Latanoprost | 373 | $6,649 |
| Loteprednol Etabonate | 36 | $5,344 |
| ValacyclovirValacyclovir Hcl | 105 | $5,080 |
| RhopressaNetarsudil Mesylate | 15 | $4,558 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 16 | $2,503 |
| Timolol Maleate | 114 | $1,933 |
| MoxifloxacinMoxifloxacin Hcl | 55 | $1,374 |
| Famciclovir | 17 | $1,246 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 47 | $1,109 |
| Difluprednate | 15 | $1,093 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Edina
- Peter BelinEdina$9K
- Jeffrey StephensEdina$7K
- Tsun Kang ChiangEdina$5K
- Ryan JohnsonEdina$4K
- Jeffrey SandersonEdina$4K
- Rhondi MeiusiEdina$3K
- Christopher StefonowiczEdina$3K
- Jess BoysenEdina$3K
- Scott SchaeferEdina$3K
- Michael ElliottEdina$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.